COOP vs. KRYS
Compare and contrast key facts about Mr. Cooper Group Inc. (COOP) and Krystal Biotech, Inc. (KRYS).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: COOP or KRYS.
Correlation
The correlation between COOP and KRYS is 0.45, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
COOP vs. KRYS - Performance Comparison
Loading data...
Key characteristics
COOP:
1.65
KRYS:
-0.30
COOP:
2.27
KRYS:
-0.22
COOP:
1.28
KRYS:
0.97
COOP:
2.64
KRYS:
-0.40
COOP:
8.29
KRYS:
-0.88
COOP:
6.38%
KRYS:
17.30%
COOP:
35.92%
KRYS:
43.96%
COOP:
-87.08%
KRYS:
-53.42%
COOP:
-4.37%
KRYS:
-37.04%
Fundamentals
COOP:
$7.63B
KRYS:
$4.03B
COOP:
$8.98
KRYS:
$4.17
COOP:
13.27
KRYS:
33.44
COOP:
3.43
KRYS:
12.08
COOP:
1.55
KRYS:
4.09
COOP:
$2.43B
KRYS:
$333.45M
COOP:
$1.29B
KRYS:
$308.79M
COOP:
$856.00M
KRYS:
$130.03M
Returns By Period
In the year-to-date period, COOP achieves a 33.68% return, which is significantly higher than KRYS's -14.13% return.
COOP
33.68%
16.68%
26.83%
58.50%
72.85%
14.55%
KRYS
-14.13%
-18.47%
-28.14%
-13.11%
17.95%
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
COOP vs. KRYS — Risk-Adjusted Performance Rank
COOP
KRYS
COOP vs. KRYS - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Mr. Cooper Group Inc. (COOP) and Krystal Biotech, Inc. (KRYS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
COOP vs. KRYS - Dividend Comparison
Neither COOP nor KRYS has paid dividends to shareholders.
Drawdowns
COOP vs. KRYS - Drawdown Comparison
The maximum COOP drawdown since its inception was -87.08%, which is greater than KRYS's maximum drawdown of -53.42%. Use the drawdown chart below to compare losses from any high point for COOP and KRYS. For additional features, visit the drawdowns tool.
Loading data...
Volatility
COOP vs. KRYS - Volatility Comparison
The current volatility for Mr. Cooper Group Inc. (COOP) is 14.10%, while Krystal Biotech, Inc. (KRYS) has a volatility of 18.92%. This indicates that COOP experiences smaller price fluctuations and is considered to be less risky than KRYS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
COOP vs. KRYS - Financials Comparison
This section allows you to compare key financial metrics between Mr. Cooper Group Inc. and Krystal Biotech, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
COOP vs. KRYS - Profitability Comparison
COOP - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Mr. Cooper Group Inc. reported a gross profit of 367.00M and revenue of 560.00M. Therefore, the gross margin over that period was 65.5%.
KRYS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Krystal Biotech, Inc. reported a gross profit of 83.16M and revenue of 88.18M. Therefore, the gross margin over that period was 94.3%.
COOP - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Mr. Cooper Group Inc. reported an operating income of 106.00M and revenue of 560.00M, resulting in an operating margin of 18.9%.
KRYS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Krystal Biotech, Inc. reported an operating income of 36.18M and revenue of 88.18M, resulting in an operating margin of 41.0%.
COOP - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Mr. Cooper Group Inc. reported a net income of 88.00M and revenue of 560.00M, resulting in a net margin of 15.7%.
KRYS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Krystal Biotech, Inc. reported a net income of 35.73M and revenue of 88.18M, resulting in a net margin of 40.5%.